Home
Mark C. McKenna, Chairman, President & CEO: Prometheus Biosciences RXDX Sell · Filed 23/02/17
Trade details
- Type
- Insider sale
- Amount
- $2,996,750
- Shares · price
- 25,000 sh · $119.87 a share
- Held after
- 55,144 sh
- Trade date
- 23/02/16
- Filed
- 23/02/17
- Days to filing
- 1 days
Sold 31.2% of holdings
- Share of holding sold
- 31.2%
Prometheus Biosciences trades, last 26 weeks
What else happened in Prometheus Biosciences around then
Filed or reported within 30 days of the trade day · 23/01/17~23/03/18Mark C. McKenna's recent trades
- Mark C. McKenna
BuyApogee Therapeutics
BuyApogee Therapeutics
APGE
$623.1K
12,500 sh
$623.1K
Filed 24/12/16
Traded 24/12/12
- Mark C. McKenna
BuyApogee Therapeutics
BuyApogee Therapeutics
APGE
$367.7K
7,500 sh
$367.7K
Filed 24/12/16
Traded 24/12/12
- Mark C. McKenna
SellPrometheus Biosciences
SellPrometheus Biosciences
RXDX
$2.9M
25,000 sh
$2.9M
Filed 23/03/17
Traded 23/03/15
- Mark C. McKenna
SellPrometheus Biosciences
SellPrometheus Biosciences
RXDX
$1.3M
10,620 sh
$1.3M
Filed 23/03/03
Traded 23/03/03
- Mark C. McKenna
SellPrometheus Biosciences
SellPrometheus Biosciences
RXDX
$87.7K
700 sh
$87.7K
Filed 23/03/03
Traded 23/03/01